IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 860 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (142 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   Methods
   Results
   Discussion
   References
   Article Tables

 Article Access Statistics
    Viewed4221    
    Printed74    
    Emailed3    
    PDF Downloaded365    
    Comments [Add]    
    Cited by others 9    

Recommend this journal

 


 
NET LETTER
Year : 2008  |  Volume : 74  |  Issue : 6  |  Page : 701

Clinical and sociodemographic study of vitiligo


Department of Dermatology, Venereology and Leprosy, Govt. Medical College, Bhavnagar, India

Correspondence Address:
Hita Shah
201, Golden Arc Apartment, Atabhai Chowk, Bhavnagar - 364 001, Gujarat
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0378-6323.45144

Rights and Permissions



How to cite this article:
Shah H, Mehta A, Astik B. Clinical and sociodemographic study of vitiligo. Indian J Dermatol Venereol Leprol 2008;74:701

How to cite this URL:
Shah H, Mehta A, Astik B. Clinical and sociodemographic study of vitiligo. Indian J Dermatol Venereol Leprol [serial online] 2008 [cited 2016 Sep 28];74:701. Available from: http://www.ijdvl.com/text.asp?2008/74/6/701/45144


Sir,

Vitiligo is a common pigmentary disorder of the skin, with a worldwide incidence of 1%. [1] Widespread prejudices, ignorance, taboos, lack of scientific appraisal, and confusion of vitiligo with leprosy - all make it a social embarrassment for the patient, [2] although the patient's life expectancy remains unaffected. [3] There is a stigma attached to vitiligo, and the families of the affected patients, particularly young females, are socially ostracized and the patients are considered unfit for marriage. [4]

Some dermatological outpatient records show the incidence of vitiligo to be 3% to 4% in India although an incidence as high as 8.8% has also been reported. [5] In the Indian states of Gujarat and Rajasthan, the prevalence of vitiligo is very high being described by some as of epidemic proportions. [6]

As Gujarat shows a high prevalence of vitiligo in India, the present study is an effort to learn more about precipitating factors and the clinical features of vitiligo patients in Bhavnagar, Gujarat.


  Methods Top


The study was conducted over a 5-year period from May 2001 to May 2006. All new patients with vitiligo attending our OPD were included in the study; patients with depigmentation caused by chemicals, burns, or another disease were excluded. The diagnosis of vitiligo in all cases was made clinically. All the patients were interrogated for a detailed history, and a meticulous examination of each patient was carried out and recorded, giving special emphasis to the duration of the disease; marital status; precipitating factors; presence of leukotrichia, Koebner's phenomenon, positive family history, and any other cutaneous or systemic illness. The sociodemographic profile of the patients was also recorded. Apart from routine blood and urine examinations, blood sugar and thyroid function tests were done whenever necessary.

Lesions confined to one or a few patches localized in a particular area were grouped as focal vitiligo; lesions distributed in a segmental/dermatomal pattern, as segmental vitiligo; lesions noted over both face and acral regions, as acrofacial vitiligo; lesions affecting many parts of the body, as vitiligo vulgaris; and lesions confined only to mucous membranes, as mucosal vitiligo. [7]


  Results Top


Incidence of vitiligo among new patients was 1.84%. A total of 365 patients were included in the study, out of which females (68.4%) were found to be more affected than males (31.6%), in a ratio of 2.1:1. The majority (32.82%) of the patients were in their second decade of life, and 58.63% of the patients were unmarried [Table 1].

A positive family history was present in 50 (13.7%) patients. Trauma (3.84%) was the most common precipitating factor, followed by emotional upset (2.19%) and physical pressure (0.82%). History of progressive vitiligo was obtained in 65.59% of the patients [Table 2].

Vitiligo vulgaris (64.9%) was the most common morphological pattern; other patterns seen were focal vitiligo (18.6%), acrofacial vitiligo (0.8%), mucosal vitiligo (14.8%), segmental vitiligo (1.4%), and universal vitiligo (8.2%). Leucotrichia was seen in 9% of the patients, and Koebner's phenomenon was noted in 6% of the patients. The associated cutaneous diseases noted in our study were alopecia areata (0.55%), chronic urticaria (0.27%), and premature canitis (0.55%).

Diabetes mellitus was found in 2(0.55%) patients; hypertension, 5(1.37%); hypothyroidism, 1(0.27%); epilepsy, 4(1%); and deafness, 5(1.37%).


  Discussion Top


The prevalence of vitiligo is high in India, varying in the range of 0.46% to 8.8%. The different ethnic backgrounds of the population residing in different geographic regions with different environmental conditions may contribute to the wide variation in the prevalence of vitiligo in India.

The female-to-male ratio in our study was 2.1:1, which is different from that reported by Handa and Kaur, Koranne et al., and Sarin et al. [7],[8],[9] Most of the reports showed that males and females were affected with almost equal frequency, but females outnumbered males in our study presumably because social stigma and marital concerns prompt women to seek early consultation. In 54.5% of the patients, the age at onset was in the first or second decade, consistent with most reports from India and the West. This shows that the disease starts at a younger age in the Indian population. However, Howtiz et al . [10] showed the age of onset to be between 40 and 60 years.

There was a family history of vitiligo in 13.7% of our patients; first-degree relatives were affected in 35 patients. Vitiligo has a polygenic or autosomal dominant inheritance pattern with incomplete penetrance and variable expression. [11],[12],[13] Familial occurrence has been reported to be in the range of 6.25% to 30%. [14] Positive family history is considered to be a poor prognostic factor for vitiligo.

A majority (65.59%) of our patients had progressive vitiligo at the time of presentation. Similarly, Dave et al. reported progressive vitiligo in 76% of the patients. [15]

In our study, vitiligo vulgaris was the most common type observed, followed by focal, mucosal, universal, segmental, and acrofacial vitiligo. The frequency of distribution of clinical types of vitiligo varies in different studies. However, according to the reports of Koranne et al. [8] and Sarin et al., [9] generalized vitiligo was found to be more common. Thus our results suggest that Indians not only have an increased incidence of the disease but also have more widespread disease.

The majority (78%) of our patients were from urban areas, where environmental pollutants are more abundant. No significant difference was found between urban and rural residents according to a study by Lu Tao in China. [16] However, Slominski et al. point out that several environmental factors, including stress, extreme exposure to pesticides, sunlight, etc., have been implicated in the etiology of vitiligo. [17]

No significant systemic illnesses were observed in our study. Autoimmune diseases were seen in 5 (1.36%) patients. The association of vitiligo with thyroid disease was 0.27% in our study but was reported to be 12% by Gopal et al. [18] Insulin-dependent diabetes mellitus is found in 1% to 7% of patients with vitiligo, [19] although it was seen in 0.55% of the patients in our study.

To conclude, vitiligo was common in younger age groups in our study settings, with females of marriageable age forming the major group. A wide variety of clinical variations was noted in our study, but no significant systemic illnesses were recorded in our patients.

 
  References Top

1.Pinkus H. Vitiligo: What is it? J Invest Dermatol 1959;32:281-4.   Back to cited text no. 1  [PUBMED]  
2.Koronne RV, Sachdevo KG. Vitiligo. Int J Dermatol 1998;27:676-81.  Back to cited text no. 2    
3.Nair BKH. Vitiligo: A retrospect. Int J Dermatol 1978;17:755-7.  Back to cited text no. 3    
4.Mehta NR, Shaha KC, Theodore C, Vyas V, Patel A. Epidemiological study of vitiligo in Surat area, South Gujarat. Indian J Med Res 1973;61:145-54.  Back to cited text no. 4    
5.Valia AK, Dutta PK. IADVL Text book and Atlas of Dermatology. Mumbai: Bhalani Publishing House; 2001. p. 608.   Back to cited text no. 5    
6.Behl PN, Kapoor TR, Majumdar M. Epidemiological study of vitiligo. Dermatol Times 1988;9:1-3.  Back to cited text no. 6    
7.Handa S, Kaur I. Vitiligo: Clinical findings in 1436 patients. J Dermatol 1999;26:653-7.   Back to cited text no. 7  [PUBMED]  
8.Koranne RV, Sehgal VN, Sachdeva KG. Clinical profile of vitiligo in North India. Indian J Dermatol Venereol Leprol 1986;52:81-2.   Back to cited text no. 8    
9.Sarin RC, Kumar AS. A clinical study of vitiligo. Indian J Dermatol Venereol Leprol 1977;43:300-14.   Back to cited text no. 9    
10.Howits J, Brodthagen H, Schwarts M, Thomsen K. Prevalence of vitiligo: Epidemiological survey the Isle of Bornholm, Denmark. Arch Dermatol 1977;113:47-52.   Back to cited text no. 10    
11.Bleehen SS, Ebling FJ, Champion RH. Disorders of skin color. In : Champion RH, Burton JL, Ebling FJ, editors. Text book of Dermatology. London: Blackwell Scientific Publications; 1992. p. 1561-622.  Back to cited text no. 11    
12.Moscher DB, Fitzpatrick TB, Hori Y, Ortonne JP. Disorders of pigmentation. In : Fitzpatick TB, Isen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in general medicine. New York: McGraw Hill; 1993. p. 903.  Back to cited text no. 12    
13.Bolognia JL, Pawelek JM. Biology of hypopigmentation. J Am Acad Dermatol 1988;19:217-55.  Back to cited text no. 13  [PUBMED]  
14.Shajil EM, Agrawal D, Vagadia K, Marfatia YS, Begum R. Vitiligo: Clinical profiles in Vadodara, Gujarat. Indian J Dermatol 2006;51:100-4.  Back to cited text no. 14    Medknow Journal
15.Dave S, Thappa DM, D'Souza M. Clinical predictors of outcome in vitiligo. Indian J Dermatol Venereol Leprol 2002;68:323-5.  Back to cited text no. 15  [PUBMED]  Medknow Journal
16.Lu T, Gao T, Wang A, Jin Y, Li Q, Li C. Vitiligo prevalence study in Shaanxi Province, China. Int J Dermatol 2007;46:47-51.  Back to cited text no. 16  [PUBMED]  [FULLTEXT]
17.Slominski, Paul A, Bomirski A. Possible role of melatonin receptors in vitiligo. J Royal Soc Med 1989;82:539-41.  Back to cited text no. 17    
18.Gopal K, Rama Rao GR, Kumar YH, Appa Rao MV, Vasudev PS. Vitiligo: A part of a systemic autoimmune process. Indian J Dermatol Venereol Leprol 2007;73:162-5.  Back to cited text no. 18  [PUBMED]  Medknow Journal
19.Huggins RH, Janusz CA, Schwartz RA. Vitiligo: A sign of systemic disease. Indian J Dermatol Venereol Leprol 2006;72:68-71.  Back to cited text no. 19  [PUBMED]  Medknow Journal



 
 
    Tables

  [Table 1], [Table 2]

This article has been cited by
1 FOXP3 is a promising and potential candidate gene in generalised vitiligo susceptibility
Parveen Jahan,Surekha Tippisetty,Prasanna L. Komaravalli
Frontiers in Genetics. 2015; 6
[Pubmed] | [DOI]
2 Profile of vitiligo among the attendants of phototherapy units in two university hospitals in Assiut, Upper Egypt
Doaa S. Sayed,Eman K. Youssef,Essam El-Den M. Mohamed,Manal M.M. Darwish
Journal of the Egyptian Women's Dermatologic Society. 2015; 12(2): 108
[Pubmed] | [DOI]
3 Advances in the treatment options for vitiligo: activated low-dose cytokines-based therapy
Torello Lotti,Jana Hercogova,Giuseppe Fabrizi
Expert Opinion on Pharmacotherapy. 2015; 16(16): 2485
[Pubmed] | [DOI]
4 Prevalence of Vitiligo and Associated Comorbidities in Korea
Hemin Lee,Mu-Hyoung Lee,Dong Youn Lee,Hee Young Kang,Ki Ho Kim,Gwang Seong Choi,Jeonghyun Shin,Hee Jung Lee,Dong Hyun Kim,Tae Heung Kim,Ai-Young Lee,Seung Chul Lee,Sanghoon Lee,Kyoung Wan Kim,Seung-Kyung Hann,Chul Jong Park,Sang Ho Oh
Yonsei Medical Journal. 2015; 56(3): 719
[Pubmed] | [DOI]
5 The clinical patterns of vitiligo “hospital-based study” in Makkah region, Saudi Arabia
M.I. Fatani,S.H. AlSharif,K.A. Alfif,A.S. Khan,W.A. Hussain,A.A. Banjar
Journal of the Saudi Society of Dermatology & Dermatologic Surgery. 2014;
[Pubmed] | [DOI]
6 A study of clinical profiles of vitiligo in different ages: an analysis of 669 outpatients
Juliano Cesar de Barros,Carlos DæApparecida Santos Machado Filho,Luiz Carlosde Abreu,Jefferson Alfredo de Barros,Francisco Macedo Paschoal,Mariliza Tiemi Nomura,Elaine Marques,Lourdes Conceição Martins
International Journal of Dermatology. 2013; : n/a
[Pubmed] | [DOI]
7 A review of the worldwide prevalence of vitiligo in children/adolescents and adults : Worldwide prevalence of vitiligo in children/adolescents and adults
Christian Krüger, Karin Uta Schallreuter
International Journal of Dermatology. 2012; : no
[VIEW] | [DOI]
8 Vitiligo patients from India (Mumbai) show differences in clinical, demographic and autoantibody profiles compared to patients in western countries : Vitiligo in Indian patients
V. Pradhan, M. Patwardhan, V. Thakkar, V. Kharkar, U. Khopkar, K. Ghosh, A.P. Weetman, D.J. Gawkrodger, E.H. Kemp
Journal of the European Academy of Dermatology and Venereology. 2011; : no
[VIEW] | [DOI]
9 Vitiligo and associated autoimmune disorders: A retrospective hospital-based study in Mumbai, India
S.A. Poojary
Allergologia et Immunopathologia. 2011;
[VIEW] | [DOI]



 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow